Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : BAER-101
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : Avenue Therapeutics
Deal Size : Undisclosed
Deal Type : Acquisition
Details : BAER-101 is a high affinity, selective modulator of the GABA A receptor system, with differential binding and modulatory properties dependent on the particular GABA A subtype.
Brand Name : BAER-101
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 08, 2022
Lead Product(s) : BAER-101
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : Avenue Therapeutics
Deal Size : Undisclosed
Deal Type : Acquisition
LOOKING FOR A SUPPLIER?